Therapies
Mistletoe therapy uses extracts from the mistletoe plant (Viscum album) as a clinician-supervised complementary therapy alongside conventional cancer treatment. It is typically considered for supporting wellbeing and quality of life—not replacing oncology care.
Use these pages to move from understanding → safety → suitability → booking: Book a mistletoe consultation, Mistletoe therapy cost, Mistletoe brands (Iscador, Abnoba Viscum, Helixor), Mistletoe therapy FAQs, and Evidence & safety for mistletoe therapy.
Different people start in different places. Use the options below to get the information you need—safely and efficiently.
A clinician-led review of your diagnosis, current treatment plan, medications/supplements, and goals—so we can advise whether mistletoe therapy can be integrated safely alongside oncology care.
Book a mistletoe consultationA clear, balanced overview of what the evidence does—and does not—show, plus safety guidance, cautions, and how we avoid interfering with your primary cancer treatment.
Read evidence & safetySee transparent pricing and what affects total cost (consultations, follow-ups, brand, and monitoring).
View mistletoe therapy costUnderstand why brands differ and how clinicians choose based on your context, tolerability, and availability.
Explore mistletoe brandsMistletoe therapy involves using a prepared extract of Viscum album under clinical guidance. In integrative oncology settings, it is usually approached as supportive care—aimed at supporting the person’s overall resilience and wellbeing during or after cancer treatment.
Suitability is individual. A responsible approach considers your diagnosis, oncology plan, medications/supplements, immune status, and personal goals. If you want a clear, clinician-led answer for your situation, start with a suitability assessment: Book a mistletoe consultation.
Most people explore mistletoe therapy because they want a structured, clinician-guided supportive option within a whole-person model of care. Patients often ask about supportive therapies when treatment affects energy, sleep, appetite, comfort, or emotional wellbeing.
The most common route is subcutaneous administration (a small injection under the skin). In clinician-supervised care, introduction is typically cautious, with attention to tolerability and your overall treatment context.
In some contexts, mistletoe may also be delivered using other routes under clinical supervision. If this is relevant, we explain the rationale, what monitoring is needed, and how it fits alongside your oncology care.
Mistletoe extracts contain bioactive compounds that are discussed in the integrative oncology literature in relation to supportive mechanisms such as immune signalling/modulation and broader wellbeing outcomes. Evidence varies by study type and outcome.
A responsible, safety-first approach separates: (1) supportive outcomes (e.g., quality of life / symptom burden) from (2) anti-cancer claims, which require strong evidence and must not be overstated. For a full, transparent summary, read: Evidence & safety for mistletoe therapy.
Mistletoe therapy is not “one-size-fits-all”. Suitability depends on your diagnosis, current oncology plan, medical history, immune status, and your medication and supplement profile.
Some people require additional caution or may be advised against mistletoe therapy depending on individual risk factors. This is why we begin with a structured review and—where appropriate—coordinate with your oncology team.
If safety is your main concern, start here: Evidence & safety for mistletoe therapy.
Most patients prefer a clear plan. A typical pathway looks like this:
To see what happens in the consultation and what to prepare, go here: Book a mistletoe consultation.
Reactions can vary from person to person. This table helps you understand what may be expected and what needs urgent medical advice. If you are unsure, contact your clinician.
| What you notice | What it may mean | What to do |
|---|---|---|
| Mild redness, warmth, or swelling at the injection site | A local reaction can occur with subcutaneous injections | Monitor and mention it at your next check-in. If it worsens rapidly or becomes very painful, contact us. |
| Mild itchiness at the injection site | Local skin sensitivity | Monitor. If widespread rash develops or you feel unwell, seek advice promptly. |
| Low-grade temperature or “flu-like” feeling (mild) | Some people report short-lived systemic reactions | Rest, hydrate, and contact us if symptoms persist, escalate, or you are on intensive cancer treatment and feel unwell. |
| Mild fatigue for a short period after dosing | A transient response can occur | Monitor. If fatigue is severe, prolonged, or impacts daily function, contact us for review. |
| Headache (mild to moderate) | Non-specific reaction (many possible causes) | If new, severe, or persistent—especially if accompanied by fever, confusion, or neck stiffness—seek urgent advice. |
| If any of the following occur, seek urgent medical advice | ||
| Difficulty breathing, wheezing, swelling of lips/face/tongue, or throat tightness | Possible serious allergic reaction | Call emergency services immediately. |
| Rapidly spreading rash or widespread hives, especially with dizziness or feeling faint | Possible significant allergic reaction | Seek urgent medical attention. |
| High fever, shaking chills, or feeling acutely unwell | Possible infection or serious systemic reaction (not specific to mistletoe—needs assessment) | Seek urgent medical advice, particularly if you are immunocompromised or undergoing chemotherapy. |
| Severe pain, increasing redness, marked swelling, blistering, or pus at the injection site | Possible infection or severe local reaction | Contact urgent care the same day. |
| Chest pain, new confusion, collapse, or severe weakness | Medical emergency (many potential causes) | Call emergency services immediately. |
Safety note: This information is general and not a substitute for medical advice. If you are receiving cancer treatment and feel suddenly unwell, seek urgent assessment. For contraindications, interactions, and detailed safety guidance, read: Evidence & safety for mistletoe therapy.
Many people search by brand name. Mistletoe therapy is available from different manufacturers, and brands can vary in formulation and presentation. We treat brand choice as a clinical decision guided by your context, tolerability, availability, and how the therapy fits into your wider plan.
Explore the brand hub: Mistletoe brands (Iscador, Abnoba Viscum, Helixor)
Costs vary because mistletoe therapy is individualised. Total cost is influenced by consultation and follow-up structure, the preparation/brand used, how the plan is delivered, and monitoring requirements.
See transparent pricing here: Mistletoe therapy cost.
We recommend reviewing safety and evidence information before starting. This includes what the literature does and does not show, common reactions and precautions, interaction considerations, and how we coordinate to avoid interfering with your primary cancer treatment.
Start here: Evidence & safety for mistletoe therapy.
Integrative cancer care often combines supportive options in a structured way. Depending on your needs, your plan may also include:
These are not automatic add-ons—your clinician will advise what is appropriate and safe for your situation.
For the full FAQ page, visit: Mistletoe therapy FAQs. Below are the most common questions.
Safety depends on your diagnosis, treatment plan, timing, and medication/supplement profile. We assess suitability and coordinate with your oncology team where appropriate before recommending any complementary therapy.
This requires careful clinician review and coordination. Suitability is individual and depends on your specific immunotherapy regimen and clinical context.
Some people experience mild local reactions or short-lived systemic symptoms. Urgent symptoms include breathing difficulty, facial/throat swelling, severe rash with dizziness, high fever with shaking chills, or severe injection-site changes. For detailed guidance, read: Evidence & safety for mistletoe therapy.
Brands can differ in formulation and presentation. Brand choice is a clinical decision based on your context, tolerability, availability, and how the therapy fits into your wider plan. Explore: Mistletoe brands (Iscador, Abnoba Viscum, Helixor).
Total cost varies because plans are personalised. It depends on consultations and follow-ups, the preparation/brand used, how the plan is delivered, and monitoring requirements. See: Mistletoe therapy cost.
No. Mistletoe therapy is offered as supportive care within an integrative approach and is not intended to replace conventional oncology treatment.
If you’re considering mistletoe therapy, the safest first step is a clinician-led suitability assessment.
Disclaimer: Mistletoe therapy is offered as supportive care within an integrative cancer care model. It is not intended to replace conventional oncology treatment. Always seek clinician guidance before starting or combining therapies.
